AUSTIN, TX, September 24, 2021 – Elligo Health Research has announced the acquisition of research practice management and clinical services firm ClinEdge in a $135 million transaction. The acquisition also includes GuideStar Research and BTC of New Bedford. The acquisition is expected to result in a large end-to-end healthcare-enabling research firm.
“This is another tremendous milestone in the evolution of GuideStar Research as a leading clinical trials research organization,” says Future Factory Managing Director Kristin Hutchins. Ms. Hutchins, who served earlier as President and CEO of GuideStar Research, sees tremendous opportunity in the integration of these companies. “The combination of each of these companies’ experience and skill sets will provide great opportunities to streamline the clinical research process from beginning to end and ultimately increase patient’s access to clinical trials.”